Olopatadine Hydrochloride 46708-0709-05
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- February 18, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA209919
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 1 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
46708-0709-05Selected1 BOTTLE in 1 CARTON (46708-709-05) / 5 mL in 1 BOTTLE